All posts by Shushu Feng

Public Relations/Investor Relations Coordinator for Theralase Technologies Inc

Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment

A Toronto based clinical-stage biopharmaceutical company is quickly advancing on what may prove to be one of the safest and most  effective cancer treatments ever developed. Theralase Technologies Inc. (“Theralase”) is conducting a pivotal Phase II clinical study, with a  primary objective of efficacy, of a cutting-edge anti-cancer treatment that utilizes laser light  activated anti-cancer … Continue reading Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment